BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 9834203)

  • 21. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.
    Guenechea G; Segovia JC; Albella B; Lamana M; Ramírez M; Regidor C; Fernández MN; Bueren JA
    Blood; 1999 Feb; 93(3):1097-105. PubMed ID: 9920860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector.
    von Kalle C; Kiem HP; Goehle S; Darovsky B; Heimfeld S; Torok-Storb B; Storb R; Schuening FG
    Blood; 1994 Nov; 84(9):2890-7. PubMed ID: 7524756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells.
    Leurs C; Jansen M; Pollok KE; Heinkelein M; Schmidt M; Wissler M; Lindemann D; Von Kalle C; Rethwilm A; Williams DA; Hanenberg H
    Hum Gene Ther; 2003 Apr; 14(6):509-19. PubMed ID: 12718762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment.
    van Hennik PB; de Koning AE; Ploemacher RE
    Blood; 1999 Nov; 94(9):3055-61. PubMed ID: 10556189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential transduction efficiency of SCID-repopulating cells derived from umbilical cord blood and granulocyte colony-stimulating factor-mobilized peripheral blood.
    Pollok KE; van Der Loo JC; Cooper RJ; Hartwell JR; Miles KR; Breese R; Williams EP; Montel A; Seshadri R; Hanenberg H; Williams DA
    Hum Gene Ther; 2001 Nov; 12(17):2095-108. PubMed ID: 11747599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient bone marrow transduction by gene transfer with allogeneic umbilical cord blood serum and plasma: an implication for clinical trials.
    Moon N; Yang SJ; Park BB; Chung YS; Lee JW; Oh IH
    Hum Gene Ther; 2008 Jul; 19(7):744-52. PubMed ID: 18557700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis.
    Woods NB; Muessig A; Schmidt M; Flygare J; Olsson K; Salmon P; Trono D; von Kalle C; Karlsson S
    Blood; 2003 Feb; 101(4):1284-9. PubMed ID: 12393514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective role of functionalized single walled carbon nanotubes enhance ex vivo expansion of hematopoietic stem and progenitor cells in human umbilical cord blood.
    Bari S; Chu PP; Lim A; Fan X; Gay FP; Bunte RM; Lim TK; Li S; Chiu GN; Hwang WY
    Nanomedicine; 2013 Nov; 9(8):1304-16. PubMed ID: 23732300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient detection and selection of immature rhesus monkey and human CD34+ hematopoietic cells expressing the enhanced green fluorescent protein (EGFP).
    Bierhuizen MF; Westerman Y; Hartong SC; Visser TP; Wognum AW; Wagemaker G
    Leukemia; 1999 Apr; 13(4):605-13. PubMed ID: 10214869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
    Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
    Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
    Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
    Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrovirally transduced CD34++ human cord blood cells generate T cells expressing high levels of the retroviral encoded green fluorescent protein marker in vitro.
    Verhasselt B; De Smedt M; Verhelst R; Naessens E; Plum J
    Blood; 1998 Jan; 91(2):431-40. PubMed ID: 9427695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased gene transfer into human cord blood cells by centrifugation-enhanced transduction in fibronectin fragment-coated tubes.
    Sanyal A; Schuening FG
    Hum Gene Ther; 1999 Nov; 10(17):2859-68. PubMed ID: 10584931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood.
    Huang GP; Pan ZJ; Jia BB; Zheng Q; Xie CG; Gu JH; McNiece IK; Wang JF
    Cell Transplant; 2007; 16(6):579-85. PubMed ID: 17912949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of parameters required for efficient lentiviral vector transduction and engraftment of human cord blood CD34(+) NOD/SCID-repopulating cells.
    Liu Y; Hangoc G; Campbell TB; Goodman M; Tao W; Pollok K; Srour EF; Broxmeyer HE
    Exp Hematol; 2008 Aug; 36(8):947-56. PubMed ID: 18640494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
    Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG
    Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lentiviral gene transfer into primary and secondary NOD/SCID repopulating cells.
    Woods NB; Fahlman C; Mikkola H; Hamaguchi I; Olsson K; Zufferey R; Jacobsen SE; Trono D; Karlsson S
    Blood; 2000 Dec; 96(12):3725-33. PubMed ID: 11090053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice.
    Lam AC; Li K; Zhang XB; Li CK; Fok TF; Chang AM; James AE; Tsang KS; Yuen PM
    Transfusion; 2001 Dec; 41(12):1567-76. PubMed ID: 11778074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Competitive repopulation assay of two gene-marked cord blood units in NOD/SCID/gammac(null) mice.
    Yahata T; Ando K; Miyatake H; Uno T; Sato T; Ito M; Kato S; Hotta T
    Mol Ther; 2004 Nov; 10(5):882-91. PubMed ID: 15509506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.